Crafting precise multivalent architectures
暂无分享,去创建一个
[1] G M Whitesides,et al. Effective inhibitors of hemagglutination by influenza virus synthesized from polymers having active ester groups. Insight into mechanism of inhibition. , 1995, Journal of medicinal chemistry.
[2] K. Kirshenbaum,et al. Clickity-click: highly functionalized peptoid oligomers generated by sequential conjugation reactions on solid-phase support. , 2006, Organic & biomolecular chemistry.
[3] Z. Sideratou,et al. Drug delivery using multifunctional dendrimers and hyperbranched polymers , 2010, Expert opinion on drug delivery.
[4] T. Kodadek,et al. High-throughput evaluation of relative cell permeability between peptoids and peptides. , 2008, Bioorganic & medicinal chemistry.
[5] H. Blackwell,et al. Construction of peptoids with all trans-amide backbones and peptoid reverse turns via the tactical incorporation of N-aryl side chains capable of hydrogen bonding. , 2010, The Journal of organic chemistry.
[6] R. Rando,et al. Specific binding of Hoechst 33258 to site 1 thymidylate synthase mRNA. , 2000, Nucleic acids research.
[7] A. Schepartz,et al. Arginine topology controls escape of minimally cationic proteins from early endosomes to the cytoplasm. , 2012, Chemistry & biology.
[8] Sachdev S Sidhu,et al. Activation of the proapoptotic death receptor DR5 by oligomeric peptide and antibody agonists. , 2006, Journal of molecular biology.
[9] W. C. Still,et al. Inhibition of gene expression in human cells through small molecule-RNA interactions. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[10] David E. Housman,et al. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member , 1992, Cell.
[11] L. Kiessling,et al. A General Synthetic Route to Defined, Biologically Active Multivalent Arrays , 1999 .
[12] Jason E Gestwicki,et al. Synthetic multivalent ligands as probes of signal transduction. , 2006, Angewandte Chemie.
[13] S. Durell,et al. Programmable Multivalent Display of Receptor Ligands using Peptide Nucleic Acid Nanoscaffolds , 2012, Nature Communications.
[14] J. Ziller,et al. Synthesis and Applications of RuCl2(CHR‘)(PR3)2: The Influence of the Alkylidene Moiety on Metathesis Activity , 1996 .
[15] P. Netti,et al. Clickable functionalization of liposomes with the gH625 peptide from Herpes simplex virus type I for intracellular drug delivery. , 2011, Chemistry.
[16] K. Kirshenbaum,et al. Tricks with clicks: modification of peptidomimetic oligomers via copper-catalyzed azide-alkyne [3 + 2] cycloaddition. , 2010, Chemical Society reviews.
[17] A. Luganini,et al. Inhibition of Herpes Simplex Virus Type 1 and Type 2 Infections by Peptide-Derivatized Dendrimers , 2011, Antimicrobial Agents and Chemotherapy.
[18] R. Pieters. Maximising multivalency effects in protein-carbohydrate interactions. , 2009, Organic & biomolecular chemistry.
[19] P. Arora,et al. Enhanced metabolic stability and protein-binding properties of artificial alpha helices derived from a hydrogen-bond surrogate: application to Bcl-xL. , 2005, Angewandte Chemie.
[20] K. Kirshenbaum,et al. Modulation of human estrogen receptor α activity by multivalent estradiol-peptidomimetic conjugates. , 2011, Molecular bioSystems.
[21] Narendra Kumar Jain,et al. Dendrimers in oncology: an expanding horizon. , 2009, Chemical reviews.
[22] Jessica L. Childs-Disney,et al. Rationally designed small molecules targeting the RNA that causes myotonic dystrophy type 1 are potently bioactive. , 2012, ACS chemical biology.
[23] G. Jayson,et al. Alpha-v Integrins as Therapeutic Targets in Oncology , 2007, Cancer investigation.
[24] D. Harlan,et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates , 1999, Nature Medicine.
[25] M. Disney,et al. Rational and modular design of potent ligands targeting the RNA that causes myotonic dystrophy 2. , 2009, ACS chemical biology.
[26] Ryan A. Mesch,et al. Free-floating ultrathin two-dimensional crystals from sequence-specific peptoid polymers. , 2010, Nature materials.
[27] Fred Schaufele,et al. The structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxy interactions. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[28] R. Mezzenga,et al. Carbon nanotubes in the liquid phase: addressing the issue of dispersion. , 2012, Small.
[29] Karen L Wooley,et al. Design of polymeric nanoparticles for biomedical delivery applications. , 2012, Chemical Society reviews.
[30] Erin E. Carlson,et al. A General Glycomimetic Strategy Yields Non-carbohydrate Inhibitors of Dc-signw , 2022 .
[31] Kai Ludwig,et al. Inhibition of influenza virus infection by multivalent sialic-acid-functionalized gold nanoparticles. , 2010, Small.
[32] K. Kirshenbaum,et al. Click to fit: versatile polyvalent display on a peptidomimetic scaffold. , 2005, Organic letters.
[33] George M Whitesides,et al. Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors. , 1998, Angewandte Chemie.
[34] Angela L. Perkins,et al. Gold nanoparticles as a platform for creating a multivalent poly-SUMO chain inhibitor that also augments ionizing radiation , 2012, Proceedings of the National Academy of Sciences.
[35] Bradford G Orr,et al. A quantitative assessment of nanoparticle-ligand distributions: implications for targeted drug and imaging delivery in dendrimer conjugates. , 2010, ACS nano.
[36] Ya‐Ping Sun,et al. Single-walled carbon nanotubes displaying multivalent ligands for capturing pathogens. , 2005, Chemical communications.
[37] O. Chaloin,et al. DNA-templated homo- and heterodimerization of peptide nucleic acid encoded oligosaccharides that mimick the carbohydrate epitope of HIV. , 2009, Angewandte Chemie.
[38] P. Prevelige,et al. Use of the interior cavity of the P22 capsid for site-specific initiation of atom-transfer radical polymerization with high-density cargo loading. , 2012, Nature chemistry.
[39] Rabe,et al. Dendronized Polymers: Synthesis, Characterization, Assembly at Interfaces, and Manipulation. , 2000, Angewandte Chemie.
[40] R. Read,et al. Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands , 2000, Nature.
[41] M. Tatham,et al. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation , 2008, Nature Cell Biology.
[42] G. O’Toole,et al. Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases. , 2012, Molecular pharmaceutics.
[43] G M Whitesides,et al. Polyacrylamides bearing pendant alpha-sialoside groups strongly inhibit agglutination of erythrocytes by influenza A virus: multivalency and steric stabilization of particulate biological systems. , 1994, Journal of medicinal chemistry.
[44] Rodney J. Ouellette,et al. Solid-Phase Synthesis of N-Substituted Glycine Oligomers (α-Peptoids) and Derivatives , 2010, Molecules.
[45] Ravi S Kane,et al. Thermodynamics of multivalent interactions: influence of the linker. , 2010, Langmuir : the ACS journal of surfaces and colloids.
[46] D. Ly,et al. Cell-permeable peptide nucleic acid designed to bind to the 5'-untranslated region of E-cadherin transcript induces potent and sequence-specific antisense effects. , 2006, Journal of the American Chemical Society.
[47] C. Schengrund,et al. Oligosaccharide-derivatized dendrimers: defined multivalent inhibitors of the adherence of the cholera toxin B subunit and the heat labile enterotoxin of E. coli to GM1 , 2004, Glycoconjugate Journal.
[48] P. Nielsen,et al. In vitro transcription and translation inhibition by anti-promyelocytic leukemia (PML)/retinoic acid receptor alpha and anti-PML peptide nucleic acid. , 1996, Blood.
[49] Christina Graf,et al. Multivalency as a chemical organization and action principle. , 2012, Angewandte Chemie.
[50] Paul J Hergenrother,et al. Targeting RNA with small molecules. , 2008, Chemical reviews.
[51] W. Santos,et al. Toward targeting RNA structure: branched peptides as cell-permeable ligands to TAR RNA. , 2012, ACS chemical biology.
[52] P. Gorry,et al. Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1. , 2011, Antiviral research.
[53] T. Ebbesen,et al. Supramolecular Self-Assembly of Lipid Derivatives on Carbon Nanotubes , 2003, Science.
[54] Anna Barnard,et al. Self-assembled multivalency: dynamic ligand arrays for high-affinity binding. , 2012, Angewandte Chemie.
[55] Marcus Weber,et al. DNA-programmed spatial screening of carbohydrate–lectin interactions , 2011 .
[56] N. Stephanopoulos,et al. Dual-surface modified virus capsids for targeted delivery of photodynamic agents to cancer cells. , 2010, ACS nano.
[57] J. Shabanowitz,et al. Androgen Receptor Phosphorylation , 2002, The Journal of Biological Chemistry.
[58] N. McKeown,et al. Polyamidoamine Starburst dendrimers as solubility enhancers. , 2000, International journal of pharmaceutics.
[59] R. Roy,et al. Design and Creativity in Synthesis of Multivalent Neoglycoconjugates , 2010, Advances in Carbohydrate Chemistry and Biochemistry.
[60] A. S. Moses,et al. Imaging and drug delivery using theranostic nanoparticles. , 2010, Advanced drug delivery reviews.
[61] R. Grubbs,et al. Synthesis and activity of a new generation of ruthenium-based olefin metathesis catalysts coordinated with 1,3-dimesityl-4,5-dihydroimidazol-2-ylidene ligands. , 1999, Organic letters.
[62] Feng Liu,et al. Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity. , 2005, Advanced drug delivery reviews.
[63] R. Evans,et al. The steroid and thyroid hormone receptor superfamily. , 1988, Science.
[64] B. Polizzotti,et al. Effects of polymer structure on the inhibition of cholera toxin by linear polypeptide-based glycopolymers. , 2006, Biomacromolecules.
[65] R. J. White,et al. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. , 2000, Science.
[66] Yonghou Jiang,et al. SPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV89.6P in macaques. , 2005, AIDS research and human retroviruses.
[67] L. Brunsveld,et al. A supramolecular polymer as a self-assembling polyvalent scaffold. , 2009, Angewandte Chemie.
[68] Ilia A Guzei,et al. Extraordinarily robust polyproline type I peptoid helices generated via the incorporation of α-chiral aromatic N-1-naphthylethyl side chains. , 2011, Journal of the American Chemical Society.
[69] T. Cooper,et al. RNA-mediated neuromuscular disorders. , 2006, Annual review of neuroscience.
[70] T. Schumacher,et al. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy , 1999, Nature Medicine.
[71] Karen L. Wooley,et al. The Importance of Chemistry in Creating Well-Defined Nanoscopic Embedded Therapeutics: Devices Capable of the Dual Functions of Imaging and Therapy , 2011, Accounts of chemical research.
[72] Jean-Luc Coll,et al. Template assembled cyclopeptides as multimeric system for integrin targeting and endocytosis. , 2004, Journal of the American Chemical Society.
[73] M. Mutter,et al. Template assembled synthetic proteins (TASP) as functional mimetics of proteins , 1996 .
[74] Using Modularly Assembled Ligands To Bind RNA Internal Loops Separated by Different Distances , 2011, Chembiochem : a European journal of chemical biology.
[75] Richard Bonneau,et al. Oligo(N-aryl glycines): a new twist on structured peptoids. , 2008, Journal of the American Chemical Society.
[76] V. Rotello,et al. Monolayer coated gold nanoparticles for delivery applications. , 2012, Advanced drug delivery reviews.
[77] Mark A. Locascio,et al. Measurements of near-ultimate strength for multiwalled carbon nanotubes and irradiation-induced crosslinking improvements. , 2008, Nature nanotechnology.
[78] Carolyn R. Bertozzi,et al. Chemical Glycobiology , 2001, Science.
[79] J. Kaldor,et al. Safety, Tolerability, and Pharmacokinetics of SPL7013 Gel (VivaGel®): A Dose Ranging, Phase I Study , 2010, Sexually transmitted diseases.
[80] Stephen P. Schoenberger,et al. T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions , 1998, Nature.
[81] H. Bien,et al. Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40 , 1999, Nature Medicine.
[82] É. Boisselier,et al. Dendrimers designed for functions: from physical, photophysical, and supramolecular properties to applications in sensing, catalysis, molecular electronics, photonics, and nanomedicine. , 2010, Chemical reviews.
[83] K. Kono,et al. Water-soluble dendritic unimolecular micelles: their potential as drug delivery agents. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[84] D. P. Mack,et al. Discovery of selective, small-molecule inhibitors of RNA complexes--I. The Tat protein/TAR RNA complexes required for HIV-1 transcription. , 1997, Bioorganic & medicinal chemistry.
[85] K. Kirshenbaum,et al. Peptoid architectures: elaboration, actuation, and application. , 2008, Current opinion in chemical biology.
[86] M. Disney,et al. Recent advances in developing small molecules targeting RNA. , 2012, ACS chemical biology.
[87] R. M. Owen,et al. Selective tumor cell targeting using low-affinity, multivalent interactions. , 2007, ACS chemical biology.
[88] D. Mann,et al. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease. , 2010, Biochemistry.
[89] Inmaculada Fernández,et al. Non-covalent functionalization of carbon nanotubes with glycolipids: glyconanomaterials with specific lectin-affinity , 2009 .
[90] H. Dai,et al. Noncovalent sidewall functionalization of single-walled carbon nanotubes for protein immobilization. , 2001, Journal of the American Chemical Society.
[91] Hongjie Dai,et al. Carbon nanotubes: synthesis, integration, and properties. , 2002, Accounts of chemical research.
[92] H. Gronemeyer,et al. Multivalent DR5 peptides activate the TRAIL death pathway and exert tumoricidal activity. , 2010, Cancer research.
[93] H. Scher,et al. Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer , 2009, Science.
[94] Kazuo Maruyama,et al. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. , 2011, Advanced drug delivery reviews.
[95] C. Curti,et al. Targeting αvβ3 Integrin: Design and Applications of Mono- and Multifunctional RGD-Based Peptides and Semipeptides , 2010 .
[96] N. Sampson,et al. Romping the cellular landscape: linear scaffolds for molecular recognition. , 2006, Current opinion in structural biology.
[97] L. Kiessling,et al. Synthetic multivalent ligands in the exploration of cell-surface interactions. , 2000, Current opinion in chemical biology.
[98] Jessica L. Childs-Disney,et al. Rational design of ligands targeting triplet repeating transcripts that cause RNA dominant disease: application to myotonic muscular dystrophy type 1 and spinocerebellar ataxia type 3. , 2009, Journal of the American Chemical Society.
[99] Walter H. Moos,et al. Comparison of the proteolytic susceptibilities of homologous L‐amino acid, D‐amino acid, and N‐substituted glycine peptide and peptoid oligomers , 1995 .
[100] Richard Bonneau,et al. Androgen receptor antagonism by divalent ethisterone conjugates in castrate-resistant prostate cancer cells. , 2012, ACS chemical biology.
[101] Kent Kirshenbaum,et al. Viral nanoparticles donning a paramagnetic coat: conjugation of MRI contrast agents to the MS2 capsid. , 2006, Nano letters.
[102] R. Grubbs,et al. A practical and highly active ruthenium-based catalyst that effects the cross metathesis of acrylonitrile. , 2002, Angewandte Chemie.
[103] K. Barylyuk,et al. Hexameric supramolecular scaffold orients carbohydrates to sense bacteria. , 2011, Journal of the American Chemical Society.
[104] Peter E. Nielsen,et al. PNA hybridizes to complementary oligonucleotides obeying the WatsonCrick hydrogen-bonding rules , 1993, Nature.
[105] E. De Clercq,et al. The regulation of HIV‐1 transcription: Molecular targets for chemotherapeutic intervention , 2006, Medicinal research reviews.
[106] J. Tschopp,et al. The molecular architecture of the TNF superfamily. , 2002, Trends in biochemical sciences.
[107] R. Kramer,et al. Spanning binding sites on allosteric proteins with polymer-linked ligand dimers , 1998, Nature.
[108] G. Whitesides,et al. Dependence of avidity on linker length for a bivalent ligand-bivalent receptor model system. , 2012, Journal of the American Chemical Society.
[109] P. Kitov,et al. On the nature of the multivalency effect: a thermodynamic model. , 2003, Journal of the American Chemical Society.
[110] Peter H. Seeberger,et al. Automated synthesis of oligosaccharides as a basis for drug discovery , 2005, Nature Reviews Drug Discovery.
[111] O. Scherman,et al. Supramolecular Glycopolymers in Water: A Reversible Route Toward Multivalent Carbohydrate–Lectin Conjugates Using Cucurbit[8]uril , 2011 .
[112] T. Mccarthy,et al. Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex viruses. , 2005, Antiviral research.
[113] D. Haddleton,et al. Probing bacterial-toxin inhibition with synthetic glycopolymers prepared by tandem post-polymerization modification: role of linker length and carbohydrate density. , 2012, Angewandte Chemie.
[114] E. Toone,et al. The cluster glycoside effect. , 2002, Chemical reviews.
[115] K. Kirshenbaum,et al. Peptoids on Steroids: Precise Multivalent Estradiol–Peptidomimetic Conjugates Generated via Azide–Alkyne [3+2] Cycloaddition Reactions , 2007 .
[116] T. Ebbesen,et al. Helical Crystallization of Proteins on Carbon Nanotubes: A First Step towards the Development of New Biosensors. , 1999, Angewandte Chemie.
[117] M. Botta,et al. High relaxivity gadolinium hydroxypyridonate-viral capsid conjugates: nanosized MRI contrast agents. , 2008, Journal of the American Chemical Society.
[118] Andrew K. Udit,et al. Defining criteria for oligomannose immunogens for HIV using icosahedral virus capsid scaffolds. , 2010, Chemistry & biology.
[119] M. Veerapandian,et al. Nanoparticles: functionalization and multifunctional applications in biomedical sciences. , 2010, Current medicinal chemistry.
[120] Marcus Weber,et al. Conformational Analysis of Bivalent Estrogen Receptor Ligands: From Intramolecular to Intermolecular Binding , 2011, Chembiochem : a European journal of chemical biology.
[121] R. Offringa,et al. C3-symmetric peptide scaffolds are functional mimetics of trimeric CD40L , 2005, Nature chemical biology.
[122] Helen E Blackwell,et al. Structure-function relationships in peptoids: recent advances toward deciphering the structural requirements for biological function. , 2009, Organic & biomolecular chemistry.
[123] J. Cochran,et al. A diverse set of oligomeric class II MHC-peptide complexes for probing T-cell receptor interactions. , 2000, Chemistry & biology.
[124] Stephen B. H. Kent,et al. Efficient method for the preparation of peptoids [oligo(N-substituted glycines)] by submonomer solid-phase synthesis , 1992 .
[125] M. Finn,et al. Cell Targeting with Hybrid Qβ Virus‐Like Particles Displaying Epidermal Growth Factor , 2011, Chembiochem : a European journal of chemical biology.
[126] Maurizio Prato,et al. Fullerene C₆₀ as a multifunctional system for drug and gene delivery. , 2011, Nanoscale.
[127] W. Jencks,et al. On the attribution and additivity of binding energies. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[128] N. Sampson,et al. Amino acid-bearing ROMP polymers with a stereoregular backbone. , 2006, Journal of the American Chemical Society.
[129] S. Naylor,et al. Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9 , 2001, Science.
[130] Paul M. Levine,et al. Multivalent peptidomimetic conjugates: a versatile platform for modulating androgen receptor activity. , 2012, Journal of the American Chemical Society.
[131] Francis C Szoka,et al. Designing dendrimers for biological applications , 2005, Nature Biotechnology.
[132] Jessica L. Childs-Disney,et al. Controlling the specificity of modularly assembled small molecules for RNA via ligand module spacing: targeting the RNAs that cause myotonic muscular dystrophy. , 2009, Journal of the American Chemical Society.
[133] Richard A. Flavell,et al. Help for cytotoxic-T-cell responses is mediated by CD40 signalling , 1998, Nature.
[134] L. Butler,et al. The contribution of different androgen receptor domains to receptor dimerization and signaling. , 2008, Molecular endocrinology.